Skip to main content
Premium Trial:

Request an Annual Quote

Great Basin Gets CE Mark for Stool Pathogens Panel

NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it has received CE marking for its stool-based bacterial pathogens detection panel.

The panel is designed to simultaneously detect Salmonella species, Shigella species, Shiga toxin-producing Escherichia coli, and Campylobacter species in stool samples. With the CE mark, the panel may now be sold in the EU and Great Britain.

Great Basin is currently awaiting a decision on the stool pathogens panel by US regulators, but the company said that a number of clinical sites in the US are evaluating the test under investigational use only (IUO) labeling.

"The value our customers have indicated they see from this product is driving early IUO validations, which will speed adoption and potentially lead to faster growth in revenues for this new panel," Great Basin Cofounder and CEO Ryan Ashton said in a statement. "We believe this product will become a major contributor to revenues in the second half of 2017 and into 2018, resulting in improved financial performance for the company."

Great Basin — which currently offers a variety of FDA-approved assays including a Staphylococcus blood culture panel, and tests for Shiga toxin, Group B Strep, Clostridium difficile, and Bordetella pertussis — has been struggling financially and was recently delisted from the Nasdaq. However, it has taken steps to improve its position, including undergoing a restructuring earlier this year.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.